BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 22486878)

  • 1. Utility of preoperative chemoradiotherapy for advanced esophageal carcinoma.
    Kuroda J; Yoshida M; Kitajima M; Yanagisawa A; Matsubara T; Yamaguchi T; Osamura Y; Ohta K; Kubota K; Beck Y; Yamashita Y
    J Gastroenterol Hepatol; 2012 Apr; 27 Suppl 3():88-94. PubMed ID: 22486878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Safety of Neoadjuvant Chemoradiotherapy Following Esophagectomy with Japanese-style Extended 3-Field Lymphadenectomy for Thoracic Esophageal Cancer.
    Motoyama S; Sato Y; Sasaki T; Wakita A; Kawakita Y; Liu J; Nagaki Y; Saito H; Imai K; Konno H; Mizusawa KT; Minamiya Y
    Anticancer Res; 2017 Oct; 37(10):5837-5843. PubMed ID: 28982909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pilot feasibility study of neoadjuvant chemoradiotherapy with S-1 in patients with locally advanced gastric cancer featuring adjacent tissue invasion or JGCA bulky N2 lymph node metastases.
    Inoue T; Yachida S; Usuki H; Kimura T; Hagiike M; Okano K; Suzuki Y
    Ann Surg Oncol; 2012 Sep; 19(9):2937-45. PubMed ID: 22466666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The number of metastatic lymph nodes and the ratio between metastatic and examined lymph nodes are independent prognostic factors in esophageal cancer regardless of neoadjuvant chemoradiation or lymphadenectomy extent.
    Mariette C; Piessen G; Briez N; Triboulet JP
    Ann Surg; 2008 Feb; 247(2):365-71. PubMed ID: 18216546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The number of pathologic lymph nodes involved is still a significant prognostic factor even after neoadjuvant chemoradiotherapy in esophageal squamous cell carcinoma.
    Akutsu Y; Shuto K; Kono T; Uesato M; Hoshino I; Shiratori T; Isozaki Y; Akanuma N; Uno T; Matsubara H
    J Surg Oncol; 2012 Jun; 105(8):756-60. PubMed ID: 22162007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nodal metastasis from locally advanced esophageal cancer: how neoadjuvant therapy modifies their frequency and distribution.
    Castoro C; Scarpa M; Cagol M; Ruol A; Cavallin F; Alfieri R; Zanchettin G; Rugge M; Ancona E
    Ann Surg Oncol; 2011 Dec; 18(13):3743-54. PubMed ID: 21556952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current status of and perspectives regarding neoadjuvant chemoradiotherapy for locally advanced esophageal squamous cell carcinoma.
    Saeki H; Nakashima Y; Zaitsu Y; Tsuda Y; Kasagi Y; Ando K; Imamura Y; Ohgaki K; Ito S; Kimura Y; Egashira A; Oki E; Morita M; Maehara Y
    Surg Today; 2016 Mar; 46(3):261-7. PubMed ID: 25740123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postchemoradiation resected locally advanced esophageal and gastroesophageal junction carcinoma: long-term outcome with or without intraoperative radiotherapy.
    Calvo FA; Sole CV; Obregón R; Gómez-Espí M; Lozano MA; Gonzalez-Bayon L; García-Sabrido JL
    Ann Surg Oncol; 2013 Jun; 20(6):1962-9. PubMed ID: 23254690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intranodal cytokeratin particles is a predictive marker of efficacy for neoadjuvant therapies in patients with squamous cell carcinoma of the esophagus.
    Lee T; Tanaka H; Ohira M; Kubo N; Sakurai K; Toyokawa T; Muguruma K; Yamashitaz Y; Maeda K; Hirakawa K
    Hepatogastroenterology; 2014; 61(133):1235-40. PubMed ID: 25436289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoadjuvant chemoradiotherapy followed by D2 gastrectomy in locally advanced gastric cancer.
    Kim MS; Lim JS; Hyung WJ; Lee YC; Rha SY; Keum KC; Koom WS
    World J Gastroenterol; 2015 Mar; 21(9):2711-8. PubMed ID: 25759540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns and timing of recurrence in esophageal squamous cell carcinoma patients treated with neoadjuvant chemoradiotherapy plus esophagectomy.
    Nagaki Y; Motoyama S; Sato Y; Wakita A; Fujita H; Sasaki Y; Imai K; Minamiya Y
    BMC Cancer; 2021 Nov; 21(1):1192. PubMed ID: 34753448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic and clinical evaluation of axillary lymph node metastasis in esophageal cancer.
    Komatsu S; Ueda Y; Ichikawa D; Fujiwara H; Okamoto K; Kikuchi S; Shiozaki A; Imura K; Ohsawa R; Ochiai T; Tsubokura T; Yamagishi H
    Jpn J Clin Oncol; 2007 Apr; 37(4):314-8. PubMed ID: 17553821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival in lymph node negative adenocarcinoma of the esophagus after R0 resection with and without neoadjuvant therapy: evidence for downstaging of N status.
    Leers JM; Ayazi S; Hagen JA; Terterov S; Klipfel N; Oezcelik A; Abate E; Lipham JC; DeMeester SR; Banki F; DeMeester TR
    J Am Coll Surg; 2009 Apr; 208(4):553-6. PubMed ID: 19476789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant chemoradiotherapy for clinical stage II-III esophageal squamous cell carcinoma.
    Saeki H; Morita M; Nakashima Y; Sonoda H; Hashimoto K; Egashira A; Oki E; Ohga T; Kakeji Y; Maehara Y
    Anticancer Res; 2011 Sep; 31(9):3073-7. PubMed ID: 21868562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.
    Pennathur A; Luketich JD; Landreneau RJ; Ward J; Christie NA; Gibson MK; Schuchert M; Cooper K; Land SR; Belani CP
    Ann Thorac Surg; 2008 Jun; 85(6):1930-6; discussion 1936-7. PubMed ID: 18498797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Impact of different extents of lymph node dissection on the survival in stage III esophageal cancer patients].
    Zhang GQ; Han F; Sun W; Pang ZL; SiKanDaer AB; Wang HJ
    Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):858-62. PubMed ID: 19173833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of lymph node metastases after neoadjuvant chemotherapy for large-sized operable carcinoma of the breast.
    Botti C; Vici P; Lopez M; Scinto AF; Cognetti F; Cavaliere R
    J Am Coll Surg; 1995 Sep; 181(3):202-8. PubMed ID: 7670678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A prospective study of combined chemoradiotherapy followed by surgery in the treatment of esophageal carcinoma].
    An FS; Huang JQ; Xie YT; Chen SH; Rong TH
    Zhonghua Zhong Liu Za Zhi; 2003 Jul; 25(4):376-9. PubMed ID: 12921571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic importance of immunohistochemically detected node metastases in resected esophageal adenocarcinoma.
    Waterman TA; Hagen JA; Peters JH; DeMeester SR; Taylor CR; Demeester TR
    Ann Thorac Surg; 2004 Oct; 78(4):1161-9; discussion 1161-9. PubMed ID: 15464464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of lymph node metastasis and survival for upper esophageal squamous cell carcinoma.
    Jang HJ; Lee HS; Kim MS; Lee JM; Zo JI
    Ann Thorac Surg; 2011 Sep; 92(3):1091-7. PubMed ID: 21704967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.